日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014

多拉韦林/拉米夫定/富马酸替诺福韦酯固定剂量复方片剂在感染 HIV 的青少年中的疗效、安全性和耐受性:IMPAACT 2014 研究中截至第 96 周的结果

Rungmaitree, Supattra; Aurpibul, Linda; Best, Brookie M; Li, Xiang; Warshaw, Meredith G; Wan, Hong; Tobin, Nicole H; Jumes, Patricia; Leavitt, Randi; McCarthy, Katie; Scheckter, Rachel; Ounchanum, Pradthana; Violari, Avy; Teppler, Hedy; Campbell, Havilland; Krotje, Chelsea; Townley, Ellen; Moye, Jack; Melvin, Ann J

Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors

HIV-1 患儿随机接受蛋白酶抑制剂或非核苷类逆转录酶抑制剂初始抗逆转录病毒治疗后,治疗中断时间

Yin, Dwight E; Ludema, Christina; Cole, Stephen R; Golin, Carol E; Miller, William C; Warshaw, Meredith G; McKinney, Ross E Jr

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

一项根据世界卫生组织儿科体重分级给药指南进行洛匹那韦/利托那韦给药的II/III期临床试验

Pinto, Jorge A; Capparelli, Edmund V; Warshaw, Meredith; Zimmer, Bonnie; Cressey, Tim R; Spector, Stephen A; Qin, Min; Smith, Betsy; Siberry, George K; Mirochnick, Mark

Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview

评估受艾滋病毒影响的青少年的精神症状:比较简短的自评量表与结构化诊断访谈

Chernoff, Miriam; Angelidou, Konstantia Nadia; Williams, Paige L; Brouwers, Pim; Warshaw, Meredith; Nachman, Sharon

Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth

既往接种过疫苗的 HIV 感染儿童和青少年接种四价脑膜炎球菌结合疫苗加强剂量的免疫原性

Warshaw, Meredith G; Siberry, George K; Williams, Paige; Decker, Michael D; Jean-Philippe, Patrick; Lujan-Zilbermann, Jorge

Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.

接受长期抑制性抗逆转录病毒治疗的 HIV 感染儿童的肝脏、肾脏、血液和炎症标志物

Melvin Ann J, Warshaw Meredith, Compagnucci Alexandra, Saidi Yacine, Harrison Linda, Turkova Anna, Tudor-Williams Gareth

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

利用CD4百分比和年龄优化儿童抗逆转录病毒治疗的启动

Yin, Dwight E; Warshaw, Meredith G; Miller, William C; Castro, Hannah; Fiscus, Susan A; Harper, Lynda M; Harrison, Linda J; Klein, Nigel J; Lewis, Joanna; Melvin, Ann J; Tudor-Williams, Gareth; McKinney, Ross E Jr

Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth

在感染 HIV 的青少年中,Toll 样受体 2 (TLR2)、TLR4、TLR9 和 FCγ 受体 II 的基因变异与四价脑膜炎球菌结合疫苗的抗体反应相关。

Spector, Stephen A; Qin, Min; Lujan-Zilbermann, Jorge; Singh, Kumud K; Warshaw, Meredith G; Williams, Paige L; Jean-Philippe, Patrick; Fenton, Terence; Siberry, George K

Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus

在感染人类免疫缺陷病毒的青少年中,接种1剂与2剂四价脑膜炎球菌结合疫苗的免疫原性和安全性比较

Lujan-Zilbermann, Jorge; Warshaw, Meredith G; Williams, Paige L; Spector, Stephen A; Decker, Michael D; Abzug, Mark J; Heckman, Barb; Manzella, Adam; Kabat, Bill; Jean-Philippe, Patrick; Nachman, Sharon; Siberry, George K

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

四价脑膜炎球菌结合疫苗在2至10岁人类免疫缺陷病毒感染儿童中的安全性和免疫原性

Siberry, George K; Warshaw, Meredith G; Williams, Paige L; Spector, Stephen A; Decker, Michael D; Jean-Philippe, Patrick; Yogev, Ram; Heckman, Barbara E; Manzella, Adam; Roa, Jhoanna; Nachman, Sharon; Lujan-Zilbermann, Jorge